Patrik Önnerfjord

Title: Innovator Patrik Önnerfjord: Pioneering Diagnostic Methods in Collagen IX Research

Introduction

Patrik Önnerfjord is a notable inventor based in Malmö, Sweden. He has made significant contributions to the field of medical diagnostics, particularly in the detection of collagen IX destruction. With a total of 2 patents, his work is paving the way for advancements in understanding and monitoring collagen-related conditions.

Latest Patents

Önnerfjord's latest patents focus on a method for detecting or monitoring the presence of protein fragments cleaved at novel sites near the N-terminal part of the collagen IX alpha 1 chain. This method is crucial for identifying changes close to the C-terminal part of the NC4 domain and at the COL3 domain near the NC3 domain. He has developed neoepitope antibodies against these cleavages, which are unique to collagen IX. Additionally, he has presented a diagnostic kit and antibodies that are useful in carrying out these methods.

Career Highlights

Throughout his career, Patrik Önnerfjord has worked with several companies, including Anamar Medical AB and Anamar AB. His expertise in the field has allowed him to contribute to innovative solutions in medical diagnostics.

Collaborations

Önnerfjord has collaborated with notable professionals in his field, including Mikael Danfelter and Dick Heinegård. These collaborations have further enhanced his research and development efforts.

Conclusion

Patrik Önnerfjord's work in the field of collagen IX diagnostics exemplifies the impact of innovative research on medical science. His patents and collaborations highlight his commitment to advancing diagnostic methods that can significantly improve patient care.